Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer

OBJECTIVE: The primary objective of this study was to evaluate the safety of niraparib 300 mg/day in Japanese patients with platinum-sensitive, relapsed ovarian cancer in a maintenance setting. METHODS: Phase 2, multicenter, open-label, single-arm study enrolled Japanese patients with platinum-sensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Takehara, Kazuhiro, Matsumoto, Takashi, Hamanishi, Junzo, Hasegawa, Kosei, Matsuura, Motoki, Miura, Kiyonori, Nagao, Shoji, Nakai, Hidekatsu, Tanaka, Naotake, Tokunaga, Hideki, Ushijima, Kimio, Watari, Hidemichi, Yokoyama, Yoshihito, Kase, Yoichi, Sumino, Shuuji, Suri, Ajit, Itamochi, Hiroaki, Takeshima, Nobuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930455/
https://www.ncbi.nlm.nih.gov/pubmed/33470063
http://dx.doi.org/10.3802/jgo.2021.32.e21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930455/
https://www.ncbi.nlm.nih.gov/pubmed/33470063
http://dx.doi.org/10.3802/jgo.2021.32.e21

Ejemplares similares